A U.S. House subcommittee focused on health issues for military veterans has scheduled a hearing for next week where members will consider two GOP-led bills concerning medical marijuana and psychedelics.
The House Veterans’ Affairs Health Subcommittee will meet on March 21 to discuss the drug policy measures, among several other veterans-focused proposals. The panel made history last November by holding a first-ever congressional hearing focused on psychedelics-assisted therapy for veterans.
One of the bills that’s on the agenda, sponsored by the subcommittee chair Rep. Mariannette Miller-Meeks (R-IA), is titled the Veterans Cannabis Analysis, Research, and Effectiveness (CARE) Act.
It would require the U.S. Department of Veterans Affairs (VA) to “conduct and support research relating to the efficacy and safety of forms of cannabis” for chronic pain, post-traumatic stress disorder (PTSD) and “other conditions the Secretary determines appropriate.”
The legislation specifies that the VA studies must involve plants and extracts, at least three varieties of cannabis with different concentrations of THC and CBD and “varying methods of cannabis delivery, including topical application, combustable and non-combustable inhalation, and ingestion.”
VA would first have to submit a research plan to House and Senate Veterans’ Affairs Committees and make any requests to support the studies. Over
Read full article on Marijuana Moment
